prognosis: typically associated with normallifeexpectancy, slowly progressive, over time muscle atrophy becomes more prominent, 1/3 of affected individuals will require a wheelchair20years after diagnosis
medical management: nocurrentdisease-modifyingtreatments, supportivemultidisciplinarycare
epidemiology: worldwide prevalence 1 per 300,000males, those with European or Asianethnicbackground